In its intimation dated June 26, 2026, the Company had informed about execution of Share Subscription and Shareholders’ Agreement (‘SSSHA’) with Sunshine Healthcare Lanka (‘Sunshine’) and Zydus Sunshine Lifesciences (‘Zydus Sunshine’) to subscribe 50% of the total paid-up equity share capital of Zydus Sunshine (‘Subscription Shares’). It was also informed that post subscription of the Subscription Shares, Zydus Sunshine shall become a 50:50 joint venture of Zydus and Sunshine. It was stated therein that the transaction of subscription of Subscription Shares and joint venture were expected to be completed within 90 working days. Vide letter dated October 1, 2026, the Company informed that the Company and Zydus Sunshine mutually agreed to extend the closing date and the transactions are expected to be completed by December 2026. Zydus Lifesciences has that the above transaction of subscription of Subscription Shares and joint venture are completed on November 11, 2026. Due to office holidays during the festive season, there was a delay in sending the intimation.
The above information is a part of company’s filings submitted to BSE.